about
Biological evaluation of transdichloridoplatinum(II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin.Serbian high-risk families: extensive results on BRCA mutation spectra and frequency.The usability of allele-specific PCR and reverse-hybridization assays for KRAS genotyping in Serbian colorectal cancer patients.Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.Synthesis, antioxidant and antiproliferative activities of 1,3,4-thiadiazoles derived from phenolic acids.RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families.Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian womenGermline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia
P50
Q42925820-30473F84-ABB5-4AC5-B840-783CD583C9C0Q46055330-144FAE03-1183-439C-B1DF-DD8608358A2AQ46700404-45902AC8-4254-4F62-B427-20FA431EBAF8Q47863122-DBE13C86-3361-4671-9FE9-08C269E0E8B2Q48163026-DC356932-7D6C-43E1-996F-0E2863206C20Q50890236-D558AB11-E1B3-4364-A132-2EA700E4917CQ50931586-7B96FF74-150F-4F4B-9C27-08ACC79723EBQ53332330-AB258B4E-9059-43CB-8335-B9E975284490Q58886632-31387B9D-F555-40E4-8C98-68980983070FQ91081319-78A3CD2B-18F8-4136-9AF9-7C7BE77EE0A2
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana Krivokuca
@ast
Ana Krivokuca
@en
Ana Krivokuca
@es
Ana Krivokuca
@nl
type
label
Ana Krivokuca
@ast
Ana Krivokuca
@en
Ana Krivokuca
@es
Ana Krivokuca
@nl
prefLabel
Ana Krivokuca
@ast
Ana Krivokuca
@en
Ana Krivokuca
@es
Ana Krivokuca
@nl
P106
P1153
36466506600
P21
P31
P496
0000-0002-1698-6981